Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.
Science Signaling - Call for Papers

Site Tools

  • AAAS
  • Subscribe
  • Feedback

Site Search

Search Advanced

Science 22 December 2006:
Vol. 314. no. 5807, pp. 1936 - 1938
DOI: 10.1126/science.1135299

Reports

Adjuvant-Enhanced Antibody Responses in the Absence of Toll-Like Receptor Signaling

Amanda L. Gavin,1 Kasper Hoebe,1 Bao Duong,1,2 Takayuki Ota,1 Christopher Martin,1,2 Bruce Beutler,1 David Nemazee1*

Innate immune signals mediated by Toll-like receptors (TLRs) have been thought to contribute considerably to the antibody-enhancing effects of vaccine adjuvants. However, we report here that mice deficient in the critical signaling components for TLR mount robust antibody responses to T cell–dependent antigen given in four typical adjuvants: alum, Freund's complete adjuvant, Freund's incomplete adjuvant, and monophosphoryl-lipid A/trehalose dicorynomycolate adjuvant. We conclude that TLR signaling does not account for the action of classical adjuvants and does not fully explain the action of a strong adjuvant containing a TLR ligand. This may have important implications in the use and development of vaccine adjuvants.

1 Department of Immunology, The Scripps Research Institute, La Jolla, CA 92037 USA.
2 The Scripps Research Institute, Kellogg School of Science and Technology, Doctoral Program in Chemical and Biological Sciences, La Jolla, CA 92037, USA.

* To whom correspondence should be addressed. E-mail: nemazee{at}scripps.edu

Read the Full Text



THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Requirements for the natural killer cell-mediated induction of IgG1 and IgG2a expression in B lymphocytes.
N. Gao, P. Jennings, and D. Yuan (2008)
Int. Immunol. 20, 645-657
   Abstract »    Full Text »    PDF »
Gr1+IL-4-producing innate cells are induced in response to Th2 stimuli and suppress Th1-dependent antibody responses.
A. S. McKee, M. MacLeod, J. White, F. Crawford, J. W. Kappler, and P. Marrack (2008)
Int. Immunol. 20, 659-669
   Abstract »    Full Text »    PDF »
Role for MyD88 Signaling in Murine Gammaherpesvirus 68 Latency.
L. M. Gargano, J. M. Moser, and S. H. Speck (2008)
J. Virol. 82, 3853-3863
   Abstract »    Full Text »    PDF »
The Adjuvants Aluminum Hydroxide and MF59 Induce Monocyte and Granulocyte Chemoattractants and Enhance Monocyte Differentiation toward Dendritic Cells.
A. Seubert, E. Monaci, M. Pizza, D. T. O'Hagan, and A. Wack (2008)
J. Immunol. 180, 5402-5412
   Abstract »    Full Text »    PDF »
Alum adjuvant boosts adaptive immunity by inducing uric acid and activating inflammatory dendritic cells.
M. Kool, T. Soullie, M. van Nimwegen, M. A.M. Willart, F. Muskens, S. Jung, H. C. Hoogsteden, H. Hammad, and B. N. Lambrecht (2008)
J. Exp. Med. 205, 869-882
   Abstract »    Full Text »    PDF »
Pivotal Advance: Eosinophils mediate early alum adjuvant-elicited B cell priming and IgM production.
H.-B. Wang and P. F. Weller (2008)
J. Leukoc. Biol. 83, 817-821
   Abstract »    Full Text »    PDF »
TLR Agonists Promote Marginal Zone B Cell Activation and Facilitate T-Dependent IgM Responses.
A. V. Rubtsov, C. L. Swanson, S. Troy, P. Strauch, R. Pelanda, and R. M. Torres (2008)
J. Immunol. 180, 3882-3888
   Abstract »    Full Text »    PDF »
Colonic Patches Direct the Cross-Talk Between Systemic Compartments and Large Intestine Independently of Innate Immunity.
S.-Y. Chang, H.-R. Cha, S. Uematsu, S. Akira, O. Igarashi, H. Kiyono, and M.-N. Kweon (2008)
J. Immunol. 180, 1609-1618
   Abstract »    Full Text »    PDF »
Ets-1 Regulates Plasma Cell Differentiation by Interfering with the Activity of the Transcription Factor Blimp-1.
S. A. John, J. L. Clements, L. M. Russell, and L. A. Garrett-Sinha (2008)
J. Biol. Chem. 283, 951-962
   Abstract »    Full Text »    PDF »
Interleukin-15 Increases Vaccine Efficacy through a Mechanism Linked to Dendritic Cell Maturation and Enhanced Antibody Titers.
K. U. Saikh, T. L. Kissner, S. Nystrom, G. Ruthel, and R. G. Ulrich (2008)
Clin. Vaccine Immunol. 15, 131-137
   Abstract »    Full Text »    PDF »
Receptor for Advanced Glycation End Products Expression on T Cells Contributes to Antigen-Specific Cellular Expansion In Vivo.
B. Moser, D. D. Desai, M. P. Downie, Y. Chen, S. F. Yan, K. Herold, A. M. Schmidt, and R. Clynes (2007)
J. Immunol. 179, 8051-8058
   Abstract »    Full Text »    PDF »
Agonists of Toll-Like Receptors 3, 4, 7, and 9 Are Candidates for Use as Adjuvants in an Outer Membrane Vaccine against Neisseria meningitidis Serogroup B.
F. Fransen, C. J. Boog, J. P. van Putten, and P. van der Ley (2007)
Infect. Immun. 75, 5939-5946
   Abstract »    Full Text »    PDF »
A protein associated with Toll-like receptor (TLR) 4 (PRAT4A) is required for TLR-dependent immune responses.
K. Takahashi, T. Shibata, S. Akashi-Takamura, T. Kiyokawa, Y. Wakabayashi, N. Tanimura, T. Kobayashi, F. Matsumoto, R. Fukui, T. Kouro, et al. (2007)
J. Exp. Med. 204, 2963-2976
   Abstract »    Full Text »    PDF »
The Lipopolysaccharide Adjuvant Effect on T Cells Relies on Nonoverlapping Contributions from the MyD88 Pathway and CD11c+ Cells.
J. P. McAleer, D. J. Zammit, L. Lefrancois, R. J. Rossi, and A. T. Vella (2007)
J. Immunol. 179, 6524-6535
   Abstract »    Full Text »    PDF »
Primary Development and Participation in a Foreign Antigen-Driven Immune Response of a Chromatin-Reactive B Cell Clonotype Are Not Influenced by TLR9 or Other MyD88-Dependent TLRs.
F. Coffey, X. Liu, and T. Manser (2007)
J. Immunol. 179, 6663-6672
   Abstract »    Full Text »    PDF »
Danger-free autoimmune disease in Aire-deficient mice.
D. H. D. Gray, I. Gavanescu, C. Benoist, and D. Mathis (2007)
PNAS 104, 18193-18198
   Abstract »    Full Text »    PDF »
Autoimmunity Stimulated by Adoptively Transferred Dendritic Cells Is Initiated by Both {alpha}beta and {gamma}{delta} T Cells but Does Not Require MyD88 Signaling.
D. A. Martin, K. Zhang, J. Kenkel, G. Hughes, E. Clark, A. Davidson, and K. B. Elkon (2007)
J. Immunol. 179, 5819-5828
   Abstract »    Full Text »    PDF »
Selective predisposition to bacterial infections in IRAK-4 deficient children: IRAK-4 dependent TLRs are otherwise redundant in protective immunity.
C.-L. Ku, H. von Bernuth, C. Picard, S.-Y. Zhang, H.-H. Chang, K. Yang, M. Chrabieh, A. C. Issekutz, C. K. Cunningham, J. Gallin, et al. (2007)
J. Exp. Med. 204, 2407-2422
   Abstract »    Full Text »    PDF »
Sustained antigen presentation can promote an immunogenic T cell response, like dendritic cell activation.
R. Obst, H.-M. van Santen, R. Melamed, A. O. Kamphorst, C. Benoist, and D. Mathis (2007)
PNAS 104, 15460-15465
   Abstract »    Full Text »    PDF »
Neisseria meningitidis PorB, a TLR2 Ligand, Induces an Antigen-Specific Eosinophil Recall Response: Potential Adjuvant for Helminth Vaccines?.
J. M. Burke, L. M. Ganley-Leal, A. Khatri, and L. M. Wetzler (2007)
J. Immunol. 179, 3222-3230
   Abstract »    Full Text »    PDF »
BAFF and MyD88 signals promote a lupuslike disease independent of T cells.
J. R. Groom, C. A. Fletcher, S. N. Walters, S. T. Grey, S. V. Watt, M. J. Sweet, M. J. Smyth, C. R. Mackay, and F. Mackay (2007)
J. Exp. Med. 204, 1959-1971
   Abstract »    Full Text »    PDF »
Immune Complex Pathophysiology.
U. E. NYDEGGER (2007)
Ann. N.Y. Acad. Sci. 1109, 66-83
   Abstract »    Full Text »    PDF »
The Vaccine Adjuvant Monophosphoryl Lipid A as a TRIF-Biased Agonist of TLR4.
V. Mata-Haro, C. Cekic, M. Martin, P. M. Chilton, C. R. Casella, and T. C. Mitchell (2007)
Science 316, 1628-1632
   Abstract »    Full Text »    PDF »
TLR Agonists Selectively Promote Terminal Plasma Cell Differentiation of B Cell Subsets Specialized in Thymus-Independent Responses.
L. Genestier, M. Taillardet, P. Mondiere, H. Gheit, C. Bella, and T. Defrance (2007)
J. Immunol. 178, 7779-7786
   Abstract »    Full Text »    PDF »
Salmonella Induces a Switched Antibody Response without Germinal Centers That Impedes the Extracellular Spread of Infection.
A. F. Cunningham, F. Gaspal, K. Serre, E. Mohr, I. R. Henderson, A. Scott-Tucker, S. M. Kenny, M. Khan, K.-M. Toellner, P. J. L. Lane, et al. (2007)
J. Immunol. 178, 6200-6207
   Abstract »    Full Text »    PDF »
Tolls and Beyond -- Many Roads to Vaccine Immunity.
B. Pulendran (2007)
N. Engl. J. Med. 356, 1776-1778
   Full Text »    PDF »
Viral induction of AID is independent of the interferon and the Toll-like receptor signaling pathways but requires NF-{kappa}B.
P. Gourzi, T. Leonova, and F. N. Papavasiliou (2007)
J. Exp. Med. 204, 259-265
   Abstract »    Full Text »    PDF »



ADVERTISEMENT
Click Me!

ADVERTISEMENT
Click Me!

To Advertise     Find Products